RIPK2—FROM “OFF-TARGET” TO CLINICAL CANDIDATE AND BEYOND

ADVERTISEMENT RETURN TO BOOKPREVChapterNEXTRIPK2—FROM “OFF-TARGET” TO CLINICAL CANDIDATE AND BEYONDKarin WormKarin WormBristol Myers Squibb, Cambridge, Massachusetts, U.S.A.More by Karin Worm and Jill HenaultJill HenaultBristol Myers Squibb, Cambridge, Massachusetts, U.S.A.More by Jill HenaultDOI: 10.1021/mc-2022-vol57.ch08Publication Date (Web):December 21, 2022Publication History Published online21 December 2022RIGHTS & PERMISSIONS2022 Medicinal Chemistry ReviewsChapter 8pp 199-219Medicinal Chemistry ReviewsVol. 57ISBN13: 9781734427455eISBN: 9781734427455 Copyright © 2022 MEDI, Inc. Published by American Chemical Society.Article Views241Altmetric-Citations-LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InReddit Read OnlinePDF (594 KB) Get e-Alerts